Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment
Alex Raben, Victoria S. Marshe, Araba Chintoh, et al.
Frontiers in Neuroscience (2018) Vol. 11
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis
Toby Pillinger, Robert A. McCutcheon, Luke Vano, et al.
The Lancet Psychiatry (2019) Vol. 7, Iss. 1, pp. 64-77
Open Access | Times Cited: 711
Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
Nicole E. MacKenzie, Chantel Kowalchuk, Sri Mahavir Agarwal, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 160
Shared Genetic Loci Between Body Mass Index and Major Psychiatric Disorders
Shahram Bahrami, Nils Eiel Steen, Alexey Shadrin, et al.
JAMA Psychiatry (2020) Vol. 77, Iss. 5, pp. 503-503
Open Access | Times Cited: 111
Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies
Nina Dedic, Heather Dworak, Courtney Zeni, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13185-13185
Open Access | Times Cited: 77
Genetic correlations of psychiatric traits with body composition and glycemic traits are sex- and age-dependent
Christopher Hübel, Héléna A. Gaspar, Jonathan R. I. Coleman, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 74
Obesity in Adolescents with Psychiatric Disorders
Ariana M. Chao, Thomas A. Wadden, Robert I. Berkowitz
Current Psychiatry Reports (2019) Vol. 21, Iss. 1
Open Access | Times Cited: 70
New discoveries for an old drug: a review of recent olanzapine research
Amir Mohammad Meftah, Elizabeth Deckler, Leslie Citrome, et al.
Postgraduate Medicine (2019) Vol. 132, Iss. 1, pp. 80-90
Closed Access | Times Cited: 57
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review
Raghunath Singh, Nicolette Stogios, Emily R. Smith, et al.
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 30
Mendelian randomization analyses identify bidirectional causal relationships of obesity with psychiatric disorders
Wenhui Chen, Jia Feng, Shuwen Jiang, et al.
Journal of Affective Disorders (2023) Vol. 339, pp. 807-814
Closed Access | Times Cited: 19
The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy
Kenya A. Costa-Dookhan, Sri Mahavir Agarwal, Araba Chintoh, et al.
Expert Opinion on Drug Safety (2019) Vol. 19, Iss. 1, pp. 43-57
Closed Access | Times Cited: 48
Brain insulin action in schizophrenia: Something borrowed and something new
Sri Mahavir Agarwal, Fernando Caravaggio, Kenya A. Costa-Dookhan, et al.
Neuropharmacology (2019) Vol. 163, pp. 107633-107633
Closed Access | Times Cited: 45
Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease
Madis Parksepp, Liisa Leppik, Kadri Koch, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 44
Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia
Tyler R. Prestwood, Roshanak Asgariroozbehani, Sally Wu, et al.
Behavioural Brain Research (2021) Vol. 402, pp. 113101-113101
Open Access | Times Cited: 37
Drugs Affecting Body Weight, Body Fat Distribution, and Metabolic Function—Mechanisms and Possible Therapeutic or Preventive Measures: an Update
Ann Verhaegen, Luc F. Van Gaal
Current Obesity Reports (2021) Vol. 10, Iss. 1, pp. 1-13
Closed Access | Times Cited: 32
Assessing a Possibility of Divergent Metabolic Responses to Diet Adjustment and Changes of Eating Behaviours in Female Schizophrenia Patients
M. Friedrich, Joanna Sadowska
Nutrients (2025) Vol. 17, Iss. 7, pp. 1198-1198
Open Access
Association between Serum Lipids and Antipsychotic Response in Schizophrenia
David D. Kim, Alasdair M. Barr, Diane Fredrikson, et al.
Current Neuropharmacology (2019) Vol. 17, Iss. 9, pp. 852-860
Open Access | Times Cited: 38
Effects of Antipsychotic Drugs: Cross Talk Between the Nervous and Innate Immune System
Ayushi Anna Dinesh, Juned Islam, Javad Khan, et al.
CNS Drugs (2020) Vol. 34, Iss. 12, pp. 1229-1251
Closed Access | Times Cited: 34
Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives
Shen-Chieh Chang, Kah Kheng Goh, Mong‐Liang Lu
World Journal of Psychiatry (2021) Vol. 11, Iss. 10, pp. 696-710
Open Access | Times Cited: 30
The impact of weight gain on antipsychotic nonadherence or discontinuation: A systematic review and meta‐analysis
Riddhita De, Emily C. C. Smith, Janani Navagnanavel, et al.
Acta Psychiatrica Scandinavica (2024) Vol. 151, Iss. 2, pp. 109-126
Open Access | Times Cited: 4
Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?
Francky Teddy Endomba, Aurel T. Tankeu, Jan René Nkeck, et al.
Lipids in Health and Disease (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 31
Changes in the blood plasma lipidome associated with effective or poor response to atypical antipsychotic treatments in schizophrenia patients
Valéria de Almeida, Guilherme L. Alexandrino, Adriano Aquino, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 101, pp. 109945-109945
Open Access | Times Cited: 31
Polygenic risk scores enhance prediction of body mass index increase in individuals with a first episode of psychosis
Gerard Muntané, Javier Vázquez‐Bourgon, Ester Sada, et al.
European Psychiatry (2023) Vol. 66, Iss. 1
Open Access | Times Cited: 10
Metabolic disorders induced by psychotropic drugs
André Scheen
Annales d Endocrinologie (2023) Vol. 84, Iss. 3, pp. 357-363
Closed Access | Times Cited: 10
Polygenic overlap with body-mass index improves prediction of treatment-resistant schizophrenia
Kevin S. O’Connell, Elise Koch, Hasan Çağın Lenk, et al.
Psychiatry Research (2023) Vol. 325, pp. 115217-115217
Open Access | Times Cited: 10
Thioridazine protects against disturbed flow-induced atherosclerosis by inhibiting RhoA/YAP-mediated endothelial inflammation
Minchun Jiang, Hanyi Ding, Yühong Huang, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 10, pp. 1977-1988
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top